Clinical characteristics | Non-DM (n = 36) | DM (n = 20) | P value |
---|---|---|---|
Age (years) | 67 ± 1 | 68 ± 2 | 0.58 |
Gender (male/female) | 28/8 | 14/6 | 0.52 |
BMI (kg/m2) | 28.2 ± 0.9 | 33.8 ± 1.6 | 0.0015* |
Blood glucose (mmol/L) | 5.9 ± 0.3 | 10.0 ± 1.0 | <0.0001* |
HbA1c (%) (mmol/mol) | 5.8 ± 0.3 (40 ± 1) | 7.5 ± 1.2 (58 ± 4) | 0.0011* |
Diabetes duration (years) | - | 11.6 ± 2.7 |  |
Diagnosed Hypertension | 29/36 | 18/20 | 0.47 |
Echocardiography | |||
Systolic BP (mmHg) | 129 ± 3 | 133 ± 4 | 0.49 |
Diastolic BP (mmHg) | 73 ± 2 | 70 ± 2 | 0.40 |
Heart rate (bpm) | 64 ± 1 | 69 ± 2 | 0.07 |
LVEDV (mL) | 104 ± 3 | 95 ± 5 | 0.20 |
LVESV (mL) | 43 ± 2 | 39 ± 4 | 0.43 |
SV (mL) | 61 ± 2 | 56 ± 3 | 0.17 |
Cardiac Output (L/min) | 3.8 ± 0.1 | 4.0 ± 0.1 | 0.47 |
Ejection Fraction (%) | 60 ± 1 | 60 ± 2 | 0.86 |
IVSd (cm) | 1.14 ± 0.04 | 1.26 ± 0.06 | 0.08 |
LVPWd (cm) | 1.05 ± 0.03 | 1.15 ± 0.06 | 0.15 |
LVIDd (cm) | 4.76 ± 0.09 | 4.72 ± 0.15 | 0.81 |
LVIDs (cm) | 3.04 ± 0.10 | 3.04 ± 0.14 | 0.99 |
LV mass (g) | 193 ± 11 | 217 ± 18 | 0.22 |
LV volume/mass (ml/g) | 0.22 ± 0.03 | 0.19 ± 0.03 | 0.23 |
E (m/sec) | 0.68 ± 0.03 | 0.79 ± 0.05 | 0.05 |
A (m/sec) | 0.69 ± 0.03 | 0.80 ± 0.05 | 0.08 |
E/A | 1.05 ± 0.08 | 0.99 ± 0.08 | 0.63 |
e' (m/sec) | 0.069 ± 0.003 | 0.067 ± 0.004 | 0.63 |
E/e' | 10.5 ± 0.8 | 12.6 ± 1.1 | 0.01* |
Decel (msec) | 226 ± 7 | 259 ± 13 | 0.02* |
LA-2D (cm) | 4.0 ± 0.1 | 4.1 ± 0.2 | 0.55 |
Medication | |||
Statins | 35/36 (97%) | 20/20 (100%) | 0.45 |
Beta-blockers | 31/36 (86%) | 15/20 (75%) | 0.30 |
ACE inhibitors/AT blockers | 19/36 (53%) | 19/20 (95%) | 0.0012# |
Calcium Channel blocker | 7/36 (19%) | 8/20 (40%) | 0.10 |
Metformin | 0/36 (0%) | 14/20 (70%) | Â |
Insulin | 0/36 (0%) | 6/20 (30%) | Â |